Victrex plc (LON:VCT) insider Timothy (Tim) J. Cooper acquired 5 shares of the stock in a transaction dated Tuesday, April 16th. The shares were bought at an average cost of GBX 2,474 ($32.33) per share, with a total value of £123.70 ($161.64).
Shares of LON:VCT traded up GBX 10 ($0.13) during midday trading on Friday, reaching GBX 2,220 ($29.01). The company had a trading volume of 581,528 shares, compared to its average volume of 274,177. The company has a market capitalization of $1.91 billion and a P/E ratio of 17.32. Victrex plc has a 52-week low of GBX 2,082 ($27.21) and a 52-week high of GBX 3,434 ($44.87).
A number of research firms have recently issued reports on VCT. Peel Hunt restated an “add” rating on shares of Victrex in a research note on Wednesday, March 27th. Liberum Capital decreased their price target on shares of Victrex from GBX 2,825 ($36.91) to GBX 2,700 ($35.28) and set a “buy” rating on the stock in a report on Thursday, January 10th. Berenberg Bank cut their target price on shares of Victrex from GBX 2,600 ($33.97) to GBX 2,550 ($33.32) and set a “hold” rating on the stock in a research report on Thursday, February 7th. JPMorgan Chase & Co. reiterated a “neutral” rating on shares of Victrex in a research report on Friday, February 1st. Finally, UBS Group downgraded shares of Victrex to a “neutral” rating and cut their target price for the stock from GBX 2,850 ($37.24) to GBX 2,575 ($33.65) in a research report on Wednesday. Two research analysts have rated the stock with a sell rating, six have assigned a hold rating and two have assigned a buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus target price of GBX 2,525.63 ($33.00).
Victrex plc, through its subsidiaries, manufactures and sells polymers worldwide. The company offers VICTREX PEEK polymer materials; and biomaterial solutions for use in spine, ortho, dental, trauma, knee, cardiovascular, and orthopedic applications. It also offers specialist solutions for medical device manufacturers.
Featured Story: Google Finance Portfolio Workaround
Receive News & Ratings for Victrex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex and related companies with MarketBeat.com's FREE daily email newsletter.